Retracted: MicroRNA‐183 suppresses retinoblastoma cell growth, invasion and migration by targeting LRP6
Authors:
- 10 February 2014
- journal article
- retracted article
- Published by Wiley in The FEBS Journal
- Vol. 281 (5) , 1355-1365
Abstract
Our study demonstrates the downregulation of microRNA‐183 (miR‐183) in retinoblastoma (RB) tissues and RB cell lines compared with normal retinal tissues. The ectopic expression of miR‐183 in the RB cell lines Y79, SO‐RB50 and WERI‐RB1 suppresses cell viability, migration and invasion. Furthermore, the Wnt co‐receptor low‐density lipoprotein receptor‐related protein 6 (LRP6) was identified as a new target of miR‐183, and restoration of the expression of LRP6 rescues the effects induced by miR‐183 in RB cells. These results indicate that miR‐183 targets and downregulates LRP6 in the growth, migration and invasion of RB cells.Keywords
This publication has 28 references indexed in Scilit:
- Retracted: MiR‐365b‐3p, down‐regulated in retinoblastoma, regulates cell cycle progression and apoptosis of human retinoblastoma cells by targeting PAX6FEBS Letters, 2013
- Stress Response of Glioblastoma Cells Mediated by miR-17-5p Targeting PTEN and the Passenger Strand miR-17-3p Targeting MDM2Oncotarget, 2012
- MiR-125b Inhibits Tumor Growth and Promotes Apoptosis of Cervical Cancer Cells by Targeting Phosphoinositide 3-Kinase Catalytic Subunit DeltaCellular Physiology and Biochemistry, 2012
- miR-17∼92 cooperates with RB pathway mutations to promote retinoblastomaGenes & Development, 2011
- miR-183 inhibits TGF-β1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cellsBMC Cancer, 2010
- The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and deathBritish Journal of Ophthalmology, 2009
- Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System projectEuropean Journal of Cancer, 2006
- miRNAs, Cancer, and Stem Cell DivisionCell, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Gliomagenesis: genetic alterations and mouse modelsNature Reviews Genetics, 2001